VTYXInvestor Events•globenewswire•August 27, 2025 at 11:02 AM

Ventyx Biosciences to Participate in Three Upcoming Investor Conferences

Sentiment:Negative (15)

Summary

SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”, “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oral therapies for patients with autoimmune, inflammatory, and neurodegenerative diseases, today announced that Company executives will participate in the following upcoming investor conferences:

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on August 27, 2025 by globenewswire